Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gil Tauber"'
Autor:
Amir Sternfeld, Moran Friedman-Gohas, Dean Ad El, Yoav Vardizer, Jacob Bejar, Shirel Rosenwasser-Weiss, Hila Kreizman Shefer, Gil Tauber, Asaf Olshinka, Iftach Yassur, Nitza Goldenberg-Cohen, Gur Ben-Yehuda
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-6 (2020)
Scientific Reports
Scientific Reports
We aimed to characterise the response of locally advanced basal cell carcinoma (BCC) to systemic treatment with Vismodegib, a Hedgehog pathway inhibitor, by changes in the expression levels of Hedgehog pathway genes. Data were collected prospectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3793409190b2c1fdeb037e5d4d3f3cf
http://link.springer.com/article/10.1038/s41598-020-58117-0
http://link.springer.com/article/10.1038/s41598-020-58117-0
Autor:
Iftach Yassur, Ehud Reich, Guy J. Ben Simon, Maya Eiger-Moscovich, Amir Abd Elkader, Gil Tauber, Ayelet Priel, Ori Berliner
Publikováno v:
American journal of ophthalmology. 207
Purpose To evaluate the effectiveness of vismodegib, a Hedgehog pathway inhibitor, in treating orbital and advanced periocular basal cell carcinoma (BCC) in Israeli multidisciplinary medical centers. Design Retrospective case series. Methods Backgrou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5908050dc9a2e90ee8e3b014fe0efe5
https://pubmed.ncbi.nlm.nih.gov/31957698
https://pubmed.ncbi.nlm.nih.gov/31957698
Publikováno v:
Journal of drugs in dermatology : JDD. 14(3)
Vismodegib, a hedgehog pathway inhibitor has been recently introduced as an oral therapy for locally advanced and metastatic basal cell carcinoma. Although treatment of patients with basal cell carcinoma with vismodegib has been associated with parti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d31434d63535defd4d39f9281d5b7633
https://pubmed.ncbi.nlm.nih.gov/25738842
https://pubmed.ncbi.nlm.nih.gov/25738842